Maria I.

Maria I. is an accomplished scientist with extensive experience in drug discovery and cancer research. Currently serving as Senior Scientist II at Blueprint Medicines since April 2019, Maria I. previously held roles at FORMA Therapeutics, Inc., and Moderna, focusing on oncology target validation and immuno-oncology, respectively. With a strong background in epigenetics, Maria I. has contributed to notable studies, including as a post-doctoral Research Fellow at Harvard Medical School, where research identified key interactions in Ewing sarcoma. Educationally, Maria I. holds a PhD in Molecular and Cellular Biology and has engaged in various research roles and training at prestigious institutions, including the Bellvitge Biomedical Research Institute and Harvard University.